Bone-associated hormone may have a role to play in type 2 diabetes management
Through the years, scientists have developed a large number of effective treatments for individuals with type 2 diabetes.
Through the years, scientists have developed a large number of effective treatments for individuals with type 2 diabetes. Doctors often recommend that these patients buy Actos and other drugs to help them better control levels of blood sugar. Recently, a hormone called osteocalcin has come to researchers' attention as a potential way to improve diabetes management.
In a paper published in the journal Cell, researchers from Columbia University reported that osteocalcin - which is produced by bone-forming cells in the body - influences blood glucose levels and fat deposition. The team suggested that this compound could present a potential method of therapy for type 2 diabetes.
In order to better understand the benefits of osteocalcin, the researchers will be teaming up with the pharmaceutical company Sanofi-aventis.
"We have spent more than a decade uncovering the biology of osteocalcin," said researcher Gerard Karsenty. "We are delighted to have Sanofi-aventis as a collaborating partner to help us continue this research."
While such avenues are being explored in the field of diabetes management, patients may opt to buy Actos and other established medications in order to control their symptoms.
|
